Operaciones de insiders

EDGAR

Natera, Inc.

Operaciones informadas por directores, ejecutivos y titulares de más del 10 % en los Formularios 3, 4 y 5 de la SEC, leídas del XML de cada presentación. Los códigos y su redacción son los de la SEC.

El Formulario 4 debe presentarse dentro de los dos días hábiles posteriores a la operación, por lo que las más recientes pueden no estar presentadas aún.

Ventana: operaciones con fecha desde el 17 nov 2025.

Compras en el mercado abierto (código P)
0 operaciones, — acciones
Ventas en el mercado abierto (código S)
546 operaciones, 1.451.822 acciones
Suma de acciones × precio por acción: 365.591.600,4009

Los totales suman las operaciones presentadas que se listan; cuentan lo informado y no miden una dirección.

Mostrando 1–50 de 653

Operaciones de insiders, las más recientes primero, según los Formularios 3, 4 y 5 de la SEC
FechaTitular informanteCódigoAdquirido o enajenadoAccionesPrecio por acción, según lo presentadoValor (derivado)Acciones poseídas despuésDirecta o indirectaCasilla de la Regla 10b5-1NotasFuente
23 jun 2029 Presentado el 25 jun 2020Brophy Michael Burkes Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor derivado: Restricted Stock Units — subyacente Common Stock (12.500)
Enajenado (D)12.5000—37.500Directa (D) No figura en esta versión del formulario
F2, F7
  • F2 Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  • F7 On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of common stock, which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. On June 23, 2020, the criteria was satisfied for the vesting of RSUs covering 12,500 shares of common stock.
Abrir presentación 0001179110-20-007780 Leído del XML de la presentación Disputar esta fila
8 jun 2029 Presentado el 10 jun 2020Brophy Michael Burkes Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor derivado: Restricted Stock Units — subyacente Common Stock (25.000)
Enajenado (D)25.0000—50.000Directa (D) No figura en esta versión del formulario
F2, F6
  • F2 Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  • F6 On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of common stock, which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. On June 8, 2020, the criteria was satisfied for the vesting of RSUs covering 25,000 shares of common stock.
Abrir presentación 0001179110-20-007206 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)40315,26
12.610,4

Derivado: acciones × precio por acción. Valor exacto 12610.40.

8210Indirecta (I) by Caraluna 1 TrustSí
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)85316,9256
26.938,676

Derivado: acciones × precio por acción. Valor exacto 26938.6760.

8125Indirecta (I) By Caraluna 1 TrustSí
F1, F3, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.4100 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)145317,8748
46.091,846

Derivado: acciones × precio por acción. Valor exacto 46091.8460.

7980Indirecta (I) By Caraluna 1 TrustSí
F1, F4, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)240319,7733
76.745,592

Derivado: acciones × precio por acción. Valor exacto 76745.5920.

7740Indirecta (I) By Caraluna 1 TrustSí
F1, F5, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)160320,0188
51.203,008

Derivado: acciones × precio por acción. Valor exacto 51203.0080.

7580Indirecta (I) By Caraluna 1 TrustSí
F1, F6, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.87 to $320.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)40322
12.880

Derivado: acciones × precio por acción. Valor exacto 12880.

7540Indirecta (I) By Caraluna 1 TrustSí
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)40323,0650
12.922,6

Derivado: acciones × precio por acción. Valor exacto 12922.6000.

7500Indirecta (I) By Caraluna 1 TrustSí
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)40315,28
12.611,2

Derivado: acciones × precio por acción. Valor exacto 12611.20.

8210Indirecta (I) By Caraluna 2 TrustSí
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)48317,3253
15.231,6144

Derivado: acciones × precio por acción. Valor exacto 15231.6144.

8162Indirecta (I) By Caraluna 2 TrustSí
F1, F7, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.5200 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)182317,9626
57.869,1932

Derivado: acciones × precio por acción. Valor exacto 57869.1932.

7980Indirecta (I) By Caraluna 2 TrustSí
F1, F8, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)240319,2167
76.612,008

Derivado: acciones × precio por acción. Valor exacto 76612.0080.

7740Indirecta (I) By Caraluna 2 TrustSí
F1, F9, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)120320,0683
38.408,196

Derivado: acciones × precio por acción. Valor exacto 38408.1960.

7620Indirecta (I) By Caraluna 2 TrustSí
F1, F10, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.9450 to $320.2600 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)80322,8750
25.830

Derivado: acciones × precio por acción. Valor exacto 25830.0000.

7540Indirecta (I) By Caraluna 2 TrustSí
F1, F11, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.62 to $323.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
11 nov 2026 Presentado el 13 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)40324,76
12.990,4

Derivado: acciones × precio por acción. Valor exacto 12990.40.

7500Indirecta (I) By Caraluna 2 TrustSí
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Abrir presentación 0001646649-26-000045 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)15304,5713
4568,5695

Derivado: acciones × precio por acción. Valor exacto 4568.5695.

217.597Directa (D) Sí
F1, F2, F3
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.24 to $304.95 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F3 Includes 38 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on October 31, 2026
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)51305,7527
15.593,3877

Derivado: acciones × precio por acción. Valor exacto 15593.3877.

217.546Directa (D) Sí
F1, F4
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.30 to $306.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)21306,4633
6435,7293

Derivado: acciones × precio por acción. Valor exacto 6435.7293.

217.525Directa (D) Sí
F1, F5
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.39 to $306.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)50308,1980
15.409,9

Derivado: acciones × precio por acción. Valor exacto 15409.9000.

217.475Directa (D) Sí
F1, F6
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.70 to $308.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)64309,0817
19.781,2288

Derivado: acciones × precio por acción. Valor exacto 19781.2288.

217.411Directa (D) Sí
F1, F7
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.7200 to $309.6450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)110310,1655
34.118,205

Derivado: acciones × precio por acción. Valor exacto 34118.2050.

217.301Directa (D) Sí
F1, F8
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.81 to $310.66 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)100311,3116
31.131,16

Derivado: acciones × precio por acción. Valor exacto 31131.1600.

217.201Directa (D) Sí
F1, F9
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.99 to $311.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)106312,1965
33.092,829

Derivado: acciones × precio por acción. Valor exacto 33092.8290.

217.095Directa (D) Sí
F1, F10
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.00 to $312.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)74313,3168
23.185,4432

Derivado: acciones × precio por acción. Valor exacto 23185.4432.

217.021Directa (D) Sí
F1, F11
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.01 to $314.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)108314,7084
33.988,5072

Derivado: acciones × precio por acción. Valor exacto 33988.5072.

216.913Directa (D) Sí
F1, F12
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.04 to $315.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)169315,4827
53.316,5763

Derivado: acciones × precio por acción. Valor exacto 53316.5763.

216.744Directa (D) Sí
F1, F13
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.0900 to $316.0750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)1838316,8674
582.402,2812

Derivado: acciones × precio por acción. Valor exacto 582402.2812.

214.906Directa (D) Sí
F1, F14
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.24 to $317.14 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)56318,1661
17.817,3016

Derivado: acciones × precio por acción. Valor exacto 17817.3016.

214.850Directa (D) Sí
F1, F15
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F15 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.36 to $318.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)105319,2993
33.526,4265

Derivado: acciones × precio por acción. Valor exacto 33526.4265.

214.745Directa (D) Sí
F1, F16
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F16 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.67 to $319.66 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)131320,0673
41.928,8163

Derivado: acciones × precio por acción. Valor exacto 41928.8163.

214.614Directa (D) Sí
F1, F17
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F17 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.67 to $320.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)51321,1191
16.377,0741

Derivado: acciones × precio por acción. Valor exacto 16377.0741.

214.563Directa (D) Sí
F1, F18
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F18 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.77 to $321.63 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)16321,85
5149,6

Derivado: acciones × precio por acción. Valor exacto 5149.60.

214.547Directa (D) Sí
F1
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)40323,8590
12.954,36

Derivado: acciones × precio por acción. Valor exacto 12954.3600.

214.507Directa (D) Sí
F1, F19
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F19 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.3800 to $324.3550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)45325,0509
14.627,2905

Derivado: acciones × precio por acción. Valor exacto 14627.2905.

214.462Directa (D) Sí
F1, F20
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F20 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.56 to $325.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0001646649-26-000044 Leído del XML de la presentación Disputar esta fila
3 nov 2026 Presentado el 4 nov 2026Brophy Michael Burkes Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)470391,49
184.000,3

Derivado: acciones × precio por acción. Valor exacto 184000.30.

45.779Directa (D) Sí
F2
  • F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2025, as modified on September 10, 2025.
Abrir presentación 0001697362-26-000024 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Fesko John Officer: PRESIDENT, CHIEF BUS. OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)7388,2001
2717,4007

Derivado: acciones × precio por acción. Valor exacto 2717.4007.

195.571Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0002010135-26-000028 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Fesko John Officer: PRESIDENT, CHIEF BUS. OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)295400,2942
118.086,789

Derivado: acciones × precio por acción. Valor exacto 118086.7890.

195.276Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0002010135-26-000028 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Rabinowitz Matthew Director · Officer: EXECUTIVE CHAIRMAN
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)17388,20
6599,4

Derivado: acciones × precio por acción. Valor exacto 6599.40.

2.117.659Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0001646382-26-000029 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Rabinowitz Matthew Director · Officer: EXECUTIVE CHAIRMAN
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)731400,2942
292.615,0602

Derivado: acciones × precio por acción. Valor exacto 292615.0602.

2.116.928Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0001646382-26-000029 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)3388,20
1164,6

Derivado: acciones × precio por acción. Valor exacto 1164.60.

217.683Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0001646649-26-000043 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)109400,2942
43.632,0678

Derivado: acciones × precio por acción. Valor exacto 43632.0678.

217.574Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0001646649-26-000043 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Brophy Michael Burkes Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)8388,0301
3104,2408

Derivado: acciones × precio por acción. Valor exacto 3104.2408.

46.566Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs) and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0001697362-26-000024 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Brophy Michael Burkes Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)317400,2942
126.893,2614

Derivado: acciones × precio por acción. Valor exacto 126893.2614.

46.249Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs) and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0001697362-26-000024 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026RABINOWITZ DANIEL Officer: SEC. AND CHIEF LEGAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)7388,20
2717,4

Derivado: acciones × precio por acción. Valor exacto 2717.40.

168.214Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0001857843-26-000033 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026RABINOWITZ DANIEL Officer: SEC. AND CHIEF LEGAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)334400,2942
133.698,2628

Derivado: acciones × precio por acción. Valor exacto 133698.2628.

167.880Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0001857843-26-000033 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)9388,2001
3493,8009

Derivado: acciones × precio por acción. Valor exacto 3493.8009.

104.733Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0002010019-26-000038 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)410400,2942
164.120,622

Derivado: acciones × precio por acción. Valor exacto 164120.6220.

104.323Directa (D) Sí
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Abrir presentación 0002010019-26-000038 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)200405,2560
81.051,2

Derivado: acciones × precio por acción. Valor exacto 81051.2000.

104.123Directa (D) Sí
F2, F3
  • F2 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.
  • F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.8500 to $405.8450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0002010019-26-000038 Leído del XML de la presentación Disputar esta fila
2 nov 2026 Presentado el 4 nov 2026Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)432406,9398
175.797,9936

Derivado: acciones × precio por acción. Valor exacto 175797.9936.

103.691Directa (D) Sí
F2, F4
  • F2 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.
  • F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.4150 to $407.3750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Abrir presentación 0002010019-26-000038 Leído del XML de la presentación Disputar esta fila

Titulares institucionales (Formulario 13F)

No hay en el almacén ninguna posición del Formulario 13F atribuida a este emisor. Un titular aún sin vincular o sin presentar está ausente, no en cero.

Titulares del 5 % (Anexos 13D y 13G)

Aquí se leen los anexos presentados en el formato estructurado de la SEC (desde finales de 2024). Los anteriores son texto libre y no se leen.

Titulares del 5 %, el evento más reciente primero, según lo presentado
TitularPorcentaje de la claseAcciones en poderFecha del eventoFormularioFuente
FMR LLC COMMON STOCK10.515.131.244,7210/30/2026 Presentado el 6 nov 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000315066-26-002940 Disputar esta fila
Abigail P. Johnson COMMON STOCK10.515.131.244,7210/30/2026 Presentado el 6 nov 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000315066-26-002940 Disputar esta fila
FMR LLC COMMON STOCK9.513.659.508,2509/30/2026 Presentado el 5 nov 2026SCHEDULE 13GAbrir presentación 0000315066-26-002810 Disputar esta fila
Abigail P. Johnson COMMON STOCK9.513.659.508,2509/30/2026 Presentado el 5 nov 2026SCHEDULE 13GAbrir presentación 0000315066-26-002810 Disputar esta fila
T. Rowe Price Associates, Inc. COMMON STOCK6.39.021.82506/30/2026 Presentado el 14 ago 2026SCHEDULE 13G/AEnmienda 4Abrir presentación 0000080255-26-000548 Disputar esta fila
Vanguard Capital Management Common Stock5.087.205.93903/31/2026 Presentado el 30 abr 2026SCHEDULE 13GAbrir presentación 0002100119-26-000780 Disputar esta fila
The Vanguard Group Common Stock0003/13/2026 Presentado el 27 mar 2026SCHEDULE 13G/AEnmienda 7Abrir presentación 0000102909-26-001882 Disputar esta fila
T. Rowe Price Associates, Inc. COMMON STOCK7.810.872.70212/31/2025 Presentado el 17 feb 2026SCHEDULE 13G/AEnmienda 3Abrir presentación 0000080255-26-000263 Disputar esta fila
JPMORGAN CHASE CO. Common Stock, par value $0.0001 per share9.112.825.64012/31/2025 Presentado el 23 ene 2026SCHEDULE 13G/AEnmienda 2Abrir presentación 0000019617-26-000064 Disputar esta fila
T. Rowe Price Associates, Inc. COMMON STOCK8.912.191.81406/30/2025 Presentado el 14 ago 2025SCHEDULE 13G/AEnmienda 2Abrir presentación 0000080255-25-000584 Disputar esta fila
JPMORGAN CHASE CO. Common Stock, par value $0.0001 per share7.710.594.25606/30/2025 Presentado el 22 jul 2025SCHEDULE 13G/AEnmienda 1Abrir presentación 0000019617-25-000544 Disputar esta fila

El porcentaje es de la clase que indica la presentación, según lo declaró el titular. Los miembros de un grupo informan cada uno las acciones del grupo, por lo que las filas no se suman.

Qué se leyó

2.119.757 presentaciones leídas, del 14 jun 2004 al 13 nov 2026: Formularios 3, 3/A, 4, 4/A, 5, 5/A.

Algunos años pueden estar incompletos mientras se sigue leyendo el archivo. Un año con pocas presentaciones aquí no afirma que se hicieran pocas.

Presentaciones leídas, por año de presentación
Año de presentaciónPresentaciones leídas
20151
2016204.322
2017202.494
2018202.048
2019193.638
2020144.184
2021224.474
202242.927
2023199.811
2024209.823
2025235.520
2026254.737

Las presentaciones anteriores a que la SEC exigiera XML se listan, pero no se extraen.

Volver a Natera, Inc.